Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications.

[1]  K. Aldape,et al.  Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. , 2002, Cancer research.

[2]  R. McLendon,et al.  Biphasic malignant meningioma: a comparative genomic hybridization study. , 2002, Clinical neuropathology.

[3]  Thomas Koschny,et al.  Comparative genomic hybridization in glioma: a meta-analysis of 509 cases. , 2002, Cancer genetics and cytogenetics.

[4]  R. McLendon,et al.  Molecular markers of prognosis in astrocytic tumors , 2002, Cancer.

[5]  Andreas von Deimling,et al.  Impact of Genotype and Morphology on the Prognosis of Glioblastoma , 2002, Journal of neuropathology and experimental neurology.

[6]  A. Twijnstra,et al.  Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2 , 2002, Genes, chromosomes & cancer.

[7]  R. Clatterbuck,et al.  The Prognostic Value of Tumor Markers in Patients with Glioblastoma Multiforme: Analysis of 32 Patients and Review of the Literature , 2001, Journal of Neuro-Oncology.

[8]  G. Fuller.  Pathology and Genetics of Tumours of the Nervous System (World Health Organization Classification of Tumours). , 2001 .

[9]  M. Prados,et al.  Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. , 2001, Cancer research.

[10]  C. James,et al.  PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. , 2001, Journal of the National Cancer Institute.

[11]  R A Betensky,et al.  Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  B. Kupelnick,et al.  Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis. , 2001, Oncology research.

[13]  K. Ichimura,et al.  The Complexity of the 7p12 Amplicon in Human Astrocytic Gliomas: Detailed Mapping of 246 Tumors , 2000, Journal of neuropathology and experimental neurology.

[14]  J. Kononen,et al.  Chromosome imbalances in familial gliomas detected by comparative genomic hybridization , 2000, Genes, chromosomes & cancer.

[15]  S. Grimmond,et al.  Cloning, mapping, and expression analysis of a gene encoding a novel mammalian EGF-related protein (SCUBE1). , 2000, Genomics.

[16]  V. Jung,et al.  Comparative genomic hybridization reveals recurrent enhancements on chromosome 20 and in one case combined amplification sites on 15q24q26 and 20p11p12 in glioblastomas. , 2000, Cancer genetics and cytogenetics.

[17]  B. Scheithauer,et al.  Mapping of the chromosome 19 q‐arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers , 2000, Genes, chromosomes & cancer.

[18]  A. Friedman,et al.  Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification. , 2000, Neuro-oncology.

[19]  T. Klockgether,et al.  Molecular Analysis of the PTEN, TP53 and CDKN2A Tumor Suppressor Genes in Long-term Survivors of Glioblastoma Multiforme , 2000, Journal of Neuro-Oncology.

[20]  A. Cianciulli,et al.  Investigation of Genetic Alterations Associated with Development and Adverse Outcome in Patients with Astrocytic Tumor , 2000, Journal of Neuro-Oncology.

[21]  A. Poustka,et al.  Comprehensive Allelotype and Genetic Analysis of 466 Human Nervous System Tumors , 2000, Journal of neuropathology and experimental neurology.

[22]  D. Louis,et al.  Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. , 2000, Journal of neurosurgery.

[23]  A. Schäffer,et al.  Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis , 2000, Genes, chromosomes & cancer.

[24]  T. Hulsebos,et al.  A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression , 2000, International journal of cancer.

[25]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. Poustka,et al.  The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability , 1999, Oncogene.

[27]  J. Olson,et al.  Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation. , 1999, International journal of oncology.

[28]  M. Kurrer,et al.  Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. , 1999, The American journal of pathology.

[29]  R. McLendon,et al.  Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. , 1999, The American journal of pathology.

[30]  V. P. Collins,et al.  Progression as exemplified by human astrocytic tumors. , 1999, Seminars in cancer biology.

[31]  D. Louis,et al.  Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. , 1999, Journal of neuropathology and experimental neurology.

[32]  B. Schlegelberger,et al.  Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24→q25 by in situ hybridization , 1999, Cytogenetic and Genome Research.

[33]  R. Mccomb,et al.  Pathology and Genetics of Tumours of the Nervous System , 1998 .

[34]  K. Ichimura,et al.  Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades , 1998, Genes, chromosomes & cancer.

[35]  S. Leenstra,et al.  Genetic sub‐types of human malignant astrocytoma correlate with survival , 1998, International journal of cancer.

[36]  K. Sasaki,et al.  Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization , 1998, Genes, chromosomes & cancer.

[37]  M. Prados,et al.  Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade , 1998, Genes, chromosomes & cancer.

[38]  D. Wechsler,et al.  MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. , 1997, Cancer research.

[39]  N. Rainov,et al.  Prognostic factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival , 1997, Journal of Neuro-Oncology.

[40]  A. Westerveld,et al.  Fine mapping of a region of common deletion on chromosome arm 10p in human glioma , 1997, Genes, chromosomes & cancer.

[41]  G. Finocchiaro,et al.  Construction of a 5-Mb YAC contig from the putative 10q25 tumor-suppressor region for glioblastomas. , 1997, Genomics.

[42]  D K Pearl,et al.  Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas , 1997, Cancer.

[43]  G. Fuller,et al.  Diagnostic discrepancies and their clinical impact in a neuropathology referral practice , 1997, Cancer.

[44]  C. Sommer,et al.  Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. , 1996, Oncogene.

[45]  Alec C. Kimmelman,et al.  Loss of heterozygosity of chromosome 10p in human gliomas. , 1996, Genomics.

[46]  M. Bilsky,et al.  Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics , 1996, Journal of Neuro-Oncology.

[47]  H. Scherthan,et al.  Detection of Complex Genetic Alterations in Human Glioblastoma Multiforme Using Comparative Genomic Hybridization , 1996, Journal of neuropathology and experimental neurology.

[48]  G. Finocchiaro,et al.  Redefinition of the coding sequence of the MXI1 gene and identification of a polymorphic repeat in the 3′ non-coding region that allows the detection of loss of heterozygosity of chromosome 10q25 in glioblastomas , 1995, Human Genetics.

[49]  R. McLendon,et al.  Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. , 1995, Oncogene.

[50]  D. Louis,et al.  Shared Allelic Losses on Chromosomes 1p and 19q Suggest a Common Origin of Oligodendroglioma and Oligoastrocytoma , 1995, Journal of neuropathology and experimental neurology.

[51]  B. Scheithauer,et al.  Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers , 1994, Cancer.

[52]  R. Wellenreuther,et al.  Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q. , 1994, Cancer research.

[53]  R. Perry,et al.  Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. , 1992, British Journal of Cancer.

[54]  P. Humphrey,et al.  Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. , 1990, Cancer research.

[55]  D. Bigner,et al.  Cytogenetics of human brain tumors. , 1990, Cancer genetics and cytogenetics.

[56]  B. Vogelstein,et al.  Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects , 1988, Journal of neuropathology and experimental neurology.

[57]  S B Green,et al.  Patient age, histologic features, and length of survival in patients with glioblastoma multiforme , 1987, Cancer.

[58]  R. McLendon,et al.  The glioblastoma multiforme in Georgia, 1977–1981 , 1985, Cancer.

[59]  A. Tsiatis,et al.  Statistical analysis of cytogenetic abnormalities in human cancer cells. , 1982, Cancer genetics and cytogenetics.

[60]  Susan M. Chang,et al.  Glioblastoma Patients Epidermal Growth Factor Receptor , and Survival in Analysis of Complex Relationships between Age , p 53 , Updated , 2001 .

[61]  Stefano Colella,et al.  Loss of Heterozygosity on Chromosome 10 Is More Extensive in Primary (De Novo) Than in Secondary Glioblastomas , 2000, Laboratory Investigation.

[62]  M. Ferguson-Smith,et al.  Analysis of pilocytic astrocytoma by comparative genomic hybridization , 2000, British Journal of Cancer.

[63]  Feng Jiang,et al.  Inferring Tree Models for Oncogenesis from Comparative Genome Hybridization Data , 1999, J. Comput. Biol..

[64]  R. McLendon,et al.  Russell and Rubinstein's pathology of tumors of the nervous system , 1998 .

[65]  J. Olson,et al.  Gene amplification as a prognostic factor in primary brain tumors. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[66]  P. Korkolopoulou,et al.  MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. , 1997, British Journal of Cancer.

[67]  V. Levin,et al.  Cancer in the nervous system , 1996 .

[68]  C. Sommer,et al.  Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[69]  A. Jauch,et al.  Copyright ©) American Society for Investigative Pathology Comparative Genomic Hybridization of Human Malignant Gliomas Reveals Multiple Amplification Sites and Nonrandom Chromosomal Gains and Losses , 2022 .